Literature DB >> 11849634

Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.

Howard A Zacur1, Bernard Hedon, Diana Mansour, Gary A Shangold, Alan C Fisher, George W Creasy.   

Abstract

OBJECTIVE: To assess the adhesive reliability of the contraceptive patch (Ortho Evra/Evra).
DESIGN: Pooled data of 3,319 women from three contraceptive studies of up to 13 treatment cycles; a subset of 325 women of the pooled data from warm and humid climates; and 30 women from a three-period, crossover exercise study.
SETTING: 184 centers. PATIENT(S): 3,349 healthy women. INTERVENTION(S): In the contraceptive studies, each treatment cycle consisted of three consecutive 7-day patches (21 days) followed by one patch-free week. During each treatment period in the exercise study, women wore the patch for 7 days and participated in one of six activities (normal activity, excluding bathing; sauna; whirlpool; treadmill; cool-water immersion; or a combination of activities) each day at a supervised health center. MAIN OUTCOME MEASURE(S): Patch adhesion. RESULT(S): In the contraceptive studies, 4.7% of patches were replaced because they fell off (1.8% [1,297 of 70,552 patches]) or became partly detached (2.9% [2,050 of 70,552 patches]); patch replacement rates in centers from a warm, humid climate were 1.7% (85 of 4,877 patches) and 2.6% (128 of 4,877 patches), respectively. Only one of 87 patches (1.1%) completely detached in the exercise study. CONCLUSION(S): The reliability of adhesion of the contraceptive patch is excellent and consistent across all studies; only 1.8% and 2.9% of patches required replacement due to complete or partial detachment, respectively. Heat, humidity, and exercise do not affect adhesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849634     DOI: 10.1016/s0015-0282(01)03262-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Skin patch and vaginal ring versus combined oral contraceptives for contraception.

Authors:  Laureen M Lopez; David A Grimes; Maria F Gallo; Laurie L Stockton; Kenneth F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

2.  Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy.

Authors:  Pier Giorgio Crosignani; Carmine Nappi; Salvatore Ronsini; Vincenzina Bruni; Silvia Marelli; Davide Sonnino
Journal:  BMC Womens Health       Date:  2009-06-30       Impact factor: 2.809

Review 3.  Transdermal delivery of combined hormonal contraception: a review of the current literature.

Authors:  Rosanna M Galzote; Sally Rafie; Rachel Teal; Sheila K Mody
Journal:  Int J Womens Health       Date:  2017-05-15

4.  Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.

Authors:  Alessandra Graziottin
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

5.  Mathematical modeling of the release of active ingredients from a contraceptive patch: ortho evra(®) as a case study.

Authors:  Grissel Trujillo-de Santiago; Carlos Patricio Sáenz-Collins; Lizette García-Arellano; Mario Moisés Álvarez
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.